Statement from FDA Commissioner Scott Gottlieb, M.D., on new steps to encourage more widespread innovation and development of new treatments for opioid use disorder - FDA Press Releases

FDA announces new steps to encourage more widespread innovation and development of new treatments for opioid use disorder

from Food and Drug Administration--Press Releases https://ift.tt/2F0L8di
via IFTTT